Symptoms
  Diagnosis
  Treatment
  Research
  Articles
  Clinical Trials
  Current Grants
  Research Symposia
  Prevalence
  Case Definition
  Profiles
CFS Assessment Symposium 
Chronic Fatigue Syndrome: What Role Does the Autonomic Nervous System Play in the Pathophysiology of the Complex Ilness?

Literature Review

  1. Alexander ME, Berde C, Triedman JK, Sundel R, Saul JP. Postural orthostatic tachycardia and chronic fatigue: a distinct subset of neurally-mediated syncope in adolescents (abstract). Proceedings of the Fourth International Conference of the American Association for Chronic Fatigue Syndrome. J CFS 1999;5(3/4):250-251.
  2. Atiga W, Rowe P, Calkins H. Management of vasovagal syncope. J Cardiovasc Electrophysiol 1999;10:874-86.
  3. Balaji S, Oslizlok PC, Allen MC, McKay CA, Gillette PC. Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 1994;23:779-85.
  4. Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993;29:201-6.
  5. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71.
  6. Bentall RP, Wood GC, Marrinam T, Dears C, Edwards RHT. A brief mental fatigue questionnaire. Br J Clin Psychol 1993;32:375-9.
  7. Bernston GG, Cacioppo JT, Quigley KS. Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychological Review 1991;98:459-487.
  8. Bloomfield DM, Sheldon R, Grubb BP, Calkins H, Sutton R. Panel consensus putting it together: a new treatment algorithm for vasovagal syncope and related disorders. Am J Cardiol 1999; 84:33Q-39Q.
  9. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995;274:961-7.
  10. Bou-Holaigah I, Calkins H, Flynn JA, Tunin C, Chang HC, Kan J S, Rowe PC. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997; 15: 239-46.
  11. Buchwald D, Pearlman T, Umali J, Schmaling K, Katon W. Functional status in chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 1996;101:364-70.
  12. Carney RM, Freedland KM, Stein PK, Skala JA, Hoffman P, Jaffee AS. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom Med 2000;62:639-47.
  13. Chobanian AV, Volicer L, Tifft CP, Gavras H, Liang C, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med 1979;301:68-73.
  14. Chu G, Wilson PC, Carter CD, Lennon VA, Roberts-Thomson IC. Intestinal pseudo-obstruction, type 1 anti-neuronal nuclear antibodies and small-cell carcinoma of the lung. J Gastro Hepatol 1993; 8:604-6.
  15. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999;353:455-8.
  16. Cohen H, Kotler M, Matar MA, Kaplan Z, Miodownik H, Cassuto. Power spectral analysis of heart rate variability in posttraumatic stress disorder patients. Biol Psychiatry 1997;41:627-9.
  17. Cohen H, Kotler M, Matar M, Kaplan Z. Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment: preliminary results. Isr Med Assoc J 2000;2:296-301.
  18. Cohen H, Kotler M, Matar MA, Kaplan Z, Loewenthal U, Miodownik H, Cassuto Y. Analysis of heart rate variability in posttraumatic stress disorder patients in response to a trauma-related reminder. Biol Psychiatry 1998;44:1054-9.
  19. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996 May;46(5):1470.
  20. Cordero DL, Sisto SA, Tapp WN, LaManca JJ, Pareja JG, Natelson BH. Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. Clin Auton Res 1996;6:329-33.
  21. Davis SD, Kator SF, Wonnett JA, Pappas BL, Sall JL. Neurally mediated hypotension in fatigued Gulf War veterans: a preliminary report. Am J Med Sci 2000;319:89-95.
  22. De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998;105:22S-26S.
  23. De Lorenzo F, Hargreaves J, Kakkar VV. Pathogenesis and management of delayed orthostatic hypotension in patients with chronic fatigue syndrome. Clin Auton Res 1997;7:185-190.
  24. De Lorenzo F, Kakkar VV. Twenty-four-hour urine analysis in patients with orthostatic hypotension and chronic fatigue syndrome (CFS). Aust N Z J Med 1996;26:849-50.
  25. De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998;105(3A):22S-26S.
  26. Delaney JP, Brodie DA. Effects of short-term psychological stress on the time and frequency domains of heart-rate variability. Percept Mot Skills 2000;91:515-24.
  27. Demitrack MA, Dale JK, Straus SE, Laue L, Listwalk SJ, Kruesi MJP, Chrousos GP, Gold PW. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metabol 1991;73:1224-1234.
  28. DeRijk RH, Boelen A, Tilders FJ, Berkenbosch F. Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 1994;19:155-163.
  29. Di Girolamo E, De Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, for refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;33:1227-30.
  30. Dishman RK, Nakamura Y, Garcia ME, Thompson RW, Dunn AL, Blair SN. Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol 2000;37:121-33.
  31. Eskander ED, Harvey HA, Givant E, Lipton A. Phase I study combining tumor necrosis factor with interferon-alpha and interleukin-2. Am J Clin Oncol 1997;20(5); 511-514.
  32. Ewing, DJ, Martyn, CN, Young, RJ, Clarke, BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-498.
  33. Fan L, Friedman DM, Woods-Brown A, Fisher M, Krilov J, Quyyumi A, Ovadia M. Characteristic head-up tilt responses of pediatric chronic fatigue syndrome (abstract #1067-51). J Am Col Cardiol. 2000;35(2):SA260.
  34. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997;102:357-64.
  35. Friedman BH, Thayer JF. Anxiety and autonomic flexibility: a cardiovascular approach. Biol Psychol 1998;49:303-23.
  36. Fukuda K, Straus SE, Hickie I, Sharpe M, Dobbins JG, Komaroff A, and the International Chronic Fatigue Syndrome Study Group. Chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Int Med 1994;121:953-9.
  37. Fuller BF. The effects of stress-anxiety and coping styles on heart rate variability. Int J Psychophysiol 1992:12:81-6.
  38. Furlan R, Jacob G, Snell M, Robertson D, Porta A, Harris P, Mosqueda-Garcia R. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 1998;98:2154-9.
  39. Goldstein JA, Mena I, Jouanne E, Lesser I. The assessment of vascular abnormalities in late life chronic fatigue syndrome by brain SPECT: comparison with late life major depressive disorder. J CFS 1995;1(1):55-79.
  40. Grady C, Anderson R, Chase GA. Fatigue in HIV-infected men receiving investigational interleukin-2. Nurs Res 1998;47(4):227-234.
  41. Grossman P, Stemmler G, Meinhardt E. Paced respiratory sinus arrhythmia as an index of cardiac parasympathetic tone during varying behavioral tasks. Psychophysiology 1990;27:404-416.
  42. Grossman P, vanBeek J, Wientjes C. A comparison of three quantification methods for estimation of respiratory sinus arrhythmia. Psychophysiology 1990;27:702-714.
  43. Grubb BP, Kosinski DJ, Boehm K, Kip K. Postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing. Pacing Clin Electrophysiol 1997;20:2205-12.
  44. Grubb BP, Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin Electrophysiol 1999;22:798-810.
  45. Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliott L. The use of head-up tilt table testing in the evaluation and management of syncope in children and adolescents. Pacing Clin Electrophysiol 1992;15:742-8.
  46. Han K, Nagel JH, Hurwitz BE, Schneiderman N. Decomposition of heart rate variability by adaptive filtering for estimation of cardiac vagal tone. In J.H. Nagel & W.M. Smith (Eds.), Bioelectric Phenomena, Electrocardiography, Electromagnetic Interactions, Neuromuscular Systems. IEEE Publishing Services, New York, 1991;13(2):660-661.
  47. Hickler RB, Thompson GR, Fox LM, Hamlin JT III. Successful treatment of orthostatic hypotension with 9-alpha fluorohydrocortisone. N Engl J Med 1959;261:788-91.
  48. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, Cobb FR, Pryor DB. A brief self-administered questionnaire to determine functional capacity (the Duke activity status index). Am J Cardiol 1989;64:651-4.
  49. Hoeldtke RD, Dworkin GE, Gaspar SR, Israel BC. Sympathotonic orthostatic hypotension: a report of four cases. Neurology 1989; 39:34-40.
  50. Hurwitz BE. Preclinical signs of autonomic neuropathy or compensatory autonomic regulation? Internat Diabetes Monitor 2000;12(1):8-10.
  51. Hurwitz BE, Nelesen RA, Saab PG, Nagel JH, Sptizer SB, Gellman MD, McCabe PM, Phillips DJ, Schneiderman N. Differential patterns of dynamic cardiovascular regulation as a function of task. Biol Psychology 1993;36:75-95.
  52. Hurwitz BE, Brownley KA, Fletcher MA, Klimas NG. Chronic fatigue syndrome: Evidence supporting the hypothesis of a behaviorally-activated neuromodulator of fatigue. J CFS 2000;6(2):45-63.
  53. Ito T, Inoue Y, Sugihara T, Yamada H, Katayama S, Kawahara R Psychiatry Autonomic function in the early stage of panic disorder: power spectral analysis of heart rate variability. Clin Neurosci 1999;53:667-72.
  54. Itoh Y, Hamada H, Imai T, Seki T, Igarashi T, Yuge K, Fukunaga Y, Yamamoto M. Antinuclear antibodies in children with chronic nonspecific complaints. Autoimmunity 1997; 25: 243-50.
  55. Jacob G, Shannon JR, Costa F, Furlan R, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Abnormal norepinephrine clearance and adrenoreceptor sensitivity in idiopathic orthostatic intolerance. Circulation 1999;99:1706-1712.
  56. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997;96:575-580.
  57. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Black B, Robertson D. The neuropathic postural tachycardia syndrome. N Engl J Med 2000;343:1008-14.
  58. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, McCready W, Huang CF, Plioplys S. A community-based study of chronic fatigue syndrome. Arch Int Med 1999;159:2129-2137.
  59. Kageyama T, Nishikido N, Kobayashi T, Kurokawa Y, Kaneko T, Kabuto M. Self-reported sleep quality, job stress, and daytime autonomic activities assessed in terms of short-term heart rate variability among male white-collar workers. Ind Health 1998;36:263-72.
  60. Karas B, Grubb BP, Boehm K, Kip K. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol 2000;23:344-51.
  61. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1998;28:1403-1410.
  62. Kovacs JA, Vogel S, Albert JM, Falloon J, Davey RT Jr, Walker RE, Polis MA, Spooner K, Metcalf JA, Baseler M, Fyfe G, Lane HC. Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996; 335(18):1350-1356.
  63. LaManca JJ, Peckerman A, Walker J, Kesil W, Cook S, Taylor A, Natelson BH. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999;19:111-20.
  64. Lange G, Wang S, DeLuca J, Natelson BH: Neuroimaging in chronic fatigue syndrome. Am J Med 1998;105(3A):50S-53S.
  65. Langewitz W, Ruddel H. Spectral analysis of heart rate variability under mental stress. Hypertens Suppl 1989;7:S32-3.
  66. Light KC, Kothandapani RV, Allen MT. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int J Psychophysiol 1998;28:157-66.
  67. Llabre MM., Saab PG, Hurwitz BE, Schneiderman N, Spitzer S, Frame CA, Phillips D. The stability of cardiovascular parameters under different behavioral challenges: one-year follow-up. Internat J Psychophysiology 1993;14, 241-248.
  68. Low PA, Opfer-Gehrking TL, McPhee BR, McPhee BR, Fealey RD, Benarroch EE, Willner CL, Suarez GA, Proper CJ, Felten JA, Huck CA, Corfits JL. Prospective evaluation of clinical characteristics of orthostatic hypotension. Mayo Clin Proc 1995;70:617-22.
  69. Low, PA. Laboratory evaluation of autonomic failure. In: PA Low (Ed.), Clinical Autonomic Disorders: Evaluation and Management. Boston: Little, Brown,1993;169-192.
  70. Low PA, McLeod JG. The autonomic neuropathies. In: PA Low (Ed.), Clinical Autonomic Disorders: Evaluation and Management. Boston: Little, Brown, 1993:397-401.
  71. Low PA, Opfer-Gehrking TL, Textor SC, Benarroch EE, Shen W K, Schondorf R, Suarez GA, Rummans TA. Postural tachycardia syndrome (POTS). Neurology 1995;45: S19-25.
  72. Low PA. Autonomic neuropathies. Curr Opin Neurol 1998;11:531-7.
  73. MacLean AR, Allen EV. Orthostatic hypotension and orthostatic tachycardia: treatment with the "head-up" bed. JAMA 1940;115:2162-7.
  74. Mahanonda N, Bhuripanyo K, Kangakagate C, Wansanit K, Kulchot B, Nademanee K, Chaithiraphan S. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 1995;130:1250-3.
  75. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metabol 1994;79:934-939.
  76. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998;280:1061-6.
  77. McNair DM, Lorr M, Droppelman LF. Profile of mood states. San Diego, CA: Educational and Industrial Testing Service;1981.
  78. Moser M, Lehofer M, Hoehn-Saric R, McLeod DR, Hildebrandt G, Steinbrenner B, Voica M, Liebmann P, Zapotoczky HG. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J Affect Disord 1998;48:115-24.
  79. Nagel JH, Han K, Hurwitz BE, Schneiderman N. Assessment and diagnostic applications of heart rate variability. Biomedical Engineering-Applications, Basis & Communication 1993;5:147-158.
  80. Papanicolaou DA, Wilder RL, Manolagas SC,  Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128(2):127-137.
  81. Peckerman A, LaManca JJ, Smith SL, Taylor A, Tiersky L, Pollet C, Korn L, Hurwitz BE, Ottenweller JE, Natelson BH. Cardiovascular stress responses and their relation to symptoms in Gulf War veterans with fatiguing illness. Psychosom Med 2000;62:509-516.
  82. Peckerman A, LaManca JJ, Smith SL, Natelson BH. CFS severity is related to reduced stroke volume and diminished blood pressure responses to mental stress (abstract). Proceedings of the Fourth International Conference of the American Association for Chronic Fatigue Syndrome. J CFS 1999;5(3/4):252-253.
  83. Peterson PK, Pheley A, Schroeppel J, Schenck C, Marshall P, Kind A, Haugland JM, Lambrecht LJ, Swan S, Goldsmith S. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Int Med 1998;158:908-14.
  84. Piccirillo G, Elvira S, Bucca C, Viola E, Cacciafesta M, Marigliano V. Abnormal passive head-up tilt test in subjects with symptoms of anxiety power spectral analysis study of heart rate and blood pressure .Int J Cardiol 1997;60:121-31.
  85. Plioplys A. Antimuscle and anti-CNS circulating antibodies in chronic fatigue syndrome. Neurology 1997;48:1717-1719.
  86. Porges SW, McCabe PM, Yongue BG. Respiratory-Heart rate interactions: Psychophysiological implications for pathophysiology and behavior. In JT Cacioppo & RE Petty (Eds), Perspectives in cardiovascular psychophysiology. New York: Guilford Press, 1982:223-264.
  87. Racciatti D, Barberio A, Vecchiet S, Pizzigallo E. Clinical and pathogenetical characterization of 238 patients of a chronic fatigue syndrome Italian center. Proceedings of the Fourth International Conference of the American Association for Chronic Fatigue Syndrome. J CFS 1999;5(3/4):61-70.
  88. Rechlin T, Weis M, Spitzer A, Kaschka WP. Are affective disorders associated with alterations of heart rate variability? J Affect Disord 1994;32:271-5.
  89. Rechlin T, Weis M, Kaschka WP. Is diurnal variation of mood associated with parasympathetic activity? J Affect Disord 1995;34:249-55.
  90. Robertson D. The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci 1999;317(2):75-77.
  91. Rowe PC, Calkins H, DeBusk K, McKenzie R, Anand R, Sharma G, Cuccherini BA, Soto N, Hohman P, Snader S, Lucas KE, Wolff M, Straus SE. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001;285:52-59.
  92. Rowe PC, Calkins H, DeBusk K, Snader S, Lucas K, Anand R, McKenzie R, Sharma G, Cuccherini BA, Soto N, Hohman P, Wolff M, Straus SE. Randomized, placebo-controlled trial of fludrocortisone to treat neurally mediated hypotension in chronic fatigue syndrome (abstract #1120-60). J Am Col Cardiol 2000;35(2):SA129.
  93. Rowe PC, Bou-Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995;345:623-4.
  94. Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 1999;135:494-9.
  95. Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998;105:15S-21S.
  96. Sandroni P, Opfer-Gehrking TL, Benarroch EE, Shen WK, Low PA. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome. Clin Autonom Res 1996;6:225-31.
  97. Schneiderman N, McCabe PM. Psychophysiologic strategies in laboratory research. In: N. Schneiderman, SM Weisse, PG Kaufman, ed. Handbook of research methods in cardiovascular behavioral medicine. New York: Plenum Press, 1989:349-364.
  98. Schondorf R, Low P. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993;43:132-137.
  99. Schondorf R, Freeman R. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999;317:117-23.
  100. Schondorf R, Benoit J, Wein T, Phaneuf D. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999;75:192-201.
  101. Schwartz RB, Garada BM, Komaroff AL, Tice HM, Gleit M, Jolesz FA, Holman BL. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. Am J Roent 1994;162:935-941.
  102. Scott WA, Pongiglione G, Bromberg BI, Schaffer MS, Deal BJ, Fish FA, Dick M. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995;76:400-2.
  103. Sheldon R, Killam S. Methodology of isoproterenol-tilt table testing in patients with syncope. J Am Coll Cardiol 1992;19:773-9.
  104. Sheng WS, Hu S, Lamkin A, Peterson PK, Chao CC. Susceptibility to immunologically mediated fatigue in C57BL/6 versus Balb/c mice. Clin Immunol Immunopathol 1996;81:161-167.
  105. Shoham S, Davenne D, Cady AB, DInarello CA, Kreuger JM. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 1987;253:R142-R149.
  106. Sisto A, Lanzillotta P, Ceccomancini A, Di Palma P, Racciatti D, Abate G, Pizzigallo E. Neurally mediated hypotension and chronic fatigue syndrome: Preliminary results (abstract). Proceedings of the Fourth International Conference of the American Association for Chronic Fatigue Syndrome. J CFS 1999;5(3/4):252.
  107. Sisto SA, LaManca JJ, Peckerman A, Natelson B. Cardiovascular responses during a cognitive stressor before and after exercise in chronic fatigue syndrome vs sedentary healthy subjects (abstract). Proceedings of the Fourth International Conference of the American Association for Chronic Fatigue Syndrome. J CFS 1999;5(3/4):256-257.
  108. Sisto SA, Tapp W, Drastal S, Bergen M, DeMasi I, Cordero D, Natelson B. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome. Clin Auton Res 1995;5, 139-143.
  109. Sloan RP, Shapiro PA, Bagiella E, Boni SM, Paik M, Bigger JT Jr, Steinman RC, Borman JM. Effect of mental stress throughout the day on cardiac autonomic control. Biol Psychol 1994;37:89-99.
  110. Smit AA, Bolweg NM, Lenders JW, Wieling W. [No strong evidence of disturbed regulation of blood pressure in chronic fatigue syndrome]. Ned Tijdschr Geneeskd 1998;142:625-8.
  111. Soetekouw PM, Lenders JW, Bleijenberg G, Thien T, van der Meer JW: Autonomic function in patients with chronic fatigue syndrome. Clin Auton Res 1999;9:334-40.
  112. Spath-Schwalbe E, Hansen K, Schmidt F, Schrezenmeier H, Marshall L, Burger K, Fehm HL, Born J. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 1998;83(5):1573-1579.
  113. Spence VA, Khan F, Belch JJ. Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome. Am J Med 2000;108:736-739.
  114. Starr KR, Antoni MH, Hurwitz BE, Rodriquez MS, Ironson G, Fletcher MA, Kumar M, Patarca R, Lutgendorf S, Quillian RE, Klimas NG, Schneiderman N. Patterns of immune, neuroendocrine and cardiovascular stress responses in men with asymptomatic human immunodeficiency virus infection. Int J Behav Med 1996;3:135-162.
  115. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 1999;50:249-61.
  116. Stein PK, Carney RM, Freedland KE, Skala JA, Kleiger RE, Rottman JN, Jaffe AS. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 2000;48:493-500.
  117. Stewart JM, Gewitz MH, Weldon A, Munoz J. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999;135:218-25.
  118. Stewart JM, Gewitz MH, Weldon A, Arlievsky N, Li K, Munoz J. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999;103:116-21.
  119. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000; 48: 218-26.
  120. Stewart J, Weldon A, Arlievsky N, Li K, Munoz J. Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome. Clin Auton Res 1998;8:221-30.
  121. Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, Hallahan C, Henle W. Acyclovir treatment of the chronic fatigue syndrome: Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988;319:1692-8.
  122. Straus SE, ed. Chronic fatigue syndrome. New York: Marcel Dekker, Inc; 1994.
  123. Streeten DHP, Bell DS. Circulating blood volume in chronic fatigue syndrome. J CFS 1998;4(1): 3-11.
  124. Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000;320:1-8.
  125. Streeten DHP: Orthostatic intolerance. A historical introduction to the pathophysiological mechanisms. Am J Med Sci. Feb 1999;317(2):78-87.
  126. Streeten DHP. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest 1990;86:1582-1588.
  127. Streeten DH: The nature of chronic fatigue. JAMA 1998;280:1094-5.
  128. Streeten DHP, Anderson GH. Delayed orthostatic intolerance. Arch Int Med 1992;152:1066-72.
  129. Streeten DH, Anderson GH Jr. The role of delayed orthostatic hypotension in the pathogenesis of chronic fatigue. Clin Auton Res 1998;8:119-24.
  130. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: Clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994;44:1675-1682.
  131. Szafarczyk A, Hery M, Laplante E, Ixart G, Assenmacher I, Kordon C. Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors. Neuroendocrinology 1980;30:369-376.
  132. Szafarczyk A, Alonso G, Ixart G, Malaval F, Nouguier-Soule J, Assenmacher I. Serotoninergic system and circadian rhythms of ACTH and corticosterone in rats. Am J Physiol 1980;239: E482-9.
  133. Takahashi Y, Ohta S, Sano A, Kuroda Y, Kaji Y, Matsuki M, Matsuo M. Does severe nutcracker phenomenon cause pediatric chronic fatigue? Clin Nephrol 2000;53:174-81.
  134. Tanaka H, Yamaguchi H, Matushima R, Tamai H. Instantaneous orthostatic hypotension in children and adolescents: a new entity of orthostatic intolerance. Pediatr Res 1999;46:691-6.
  135. Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatry 1996;39:255-66.
  136. Tomada A, Miike T, Yamada E, Honda H, Moroi T, Ogawa M, Ohtani Y, Morishita S. Chronic fatigue syndrome in childhood. Brain Dev 2000;22:60-64.
  137. van de Luit L, van der Meulen J, Cleophas TJM, Zwinderman AH. Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not melatonin. Angiology 1998;49:903-908.
  138. Van Gool J, Van Vugt H, Helle M, Aarden LA. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990;57:200-210.
  139. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry 1996;60:489-94.
  140. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998;50:1806-13.
  141. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. New Engl J Med 2000;343:847-855.
  142. Vinik AI, Hollalnd MT, LeBeau JT, Liuzzi FJ, Stansberry KB, Colen LB. Diabetic neuropathies. Diabetes Care 1992;26-1975.
  143. Ward CR, Gray JC, Gilroy JJ, Kenny RA. Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998;79:45-9.
  144. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Medical Care 1992;30:473-83.
  145. Weiling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Autonom Res 1993;3:57-65.
  146. Wilke WS, Fouad-Terazi FM, Cash JM, Calabrese LH. The connection between chronic fatigue syndrome and neurally mediated hypotension. Cleveland Clin J Med 1998;65(5):261-266.
  147. Williams G, Pirmohamed J, Minors D, Waterhouse J, Buchan I, Arendt J, Edwards RHT. Dissociations of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome. Clinical Physiology 1996;16:327-337.
  148. Yeragani VK, Sobolewski E, Igel G, Johnson C, Jampala VC, Kay J, Hillman N, Yeragani S, Vempati S. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res 1998;78:89-99.
  149. Zeng C, Zhu Z, Liu G, Hu W, Wang X, Yang C, Wang H, He D, Tan J. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope. Am Heart J 1998;136:852-8.